Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): A phase 3, randomised, double-blind, placebo-controlled trial

Justo Garcia De Yebenes, Bernhard Landwehrmeyer, Ferdinando Squitieri, Ralf Reilmann, Anne Rosser, Roger A. Barker, Carsten Saft, Markus K. Magnet, Alastair Sword, åsa Rembratt, Joakim Tedroff

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): A phase 3, randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences